Pluristem Therapeutics Reaches New 12-Month High at $3.80 (PSTI)
Pluristem Therapeutics (NASDAQ:PSTI) set a new 52-week high on Thursday, Stock Ratings News reports. The company traded as high as $3.80 and last traded at $3.80, with a volume of 589,341 shares. The stock had previously closed at $3.52.
Pluristem Therapeutics has a 52 week low of $2.47 and a 52 week high of $3.75. The stock’s 50-day moving average is $3.28 and its 200-day moving average is $3.20. The company’s market cap is $225.8 million.
Pluristem Therapeutics Inc (NASDAQ:PSTI) is a bio-therapeutics company engaged in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.